The immune checkpoint inhibitor cemiplimab-rwlc was approved in combination with chemotherapy for certain patients with non-small cell lung cancer. The U.S. Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) in combination with platinum-based...
Female patients less likely than men to be told about sexual side effects of treatment, and more from this week in cancer news.
Research has linked highly processed foods like deli meat to a higher risk of colorectal cancer in men.
Clinical trial finds select breast cancer patients can forgo surgery, and more from the week in cancer news.
The FDA granted accelerated approval to a targeted immunotherapy for patients with relapsed or refractory multiple myeloma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to teclistamab-cqyv (Tecvayli), a type of...
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors
The FDA approved the combination of two checkpoint inhibitors for certain patients with hepatocellular carcinoma. The U.S. Food and Drug Administration (FDA) has approved tremelimumab (Imjudo) in combination with durvalumab (Imfinzi) for adult patients...
Chemical hair straightening is associated with higher uterine cancer risk, and more from the week in cancer news.
New findings may help physicians monitor for adverse reactions to immunotherapy and allow for early intervention. A potentially severe side effect of an immunotherapy used for some types of cancer may be linked to...
AACR patient advocate forum addresses developments in cancer early detection tests.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now